Non-invasive energy upconversion methods and systems
US-9526913-B2 · Dec 27, 2016 · US
US2016346392A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016346392-A1 |
| Application number | US-201415103656-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 19, 2014 |
| Priority date | Dec 20, 2013 |
| Publication date | Dec 1, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A pulse photodynamic therapy (or pulse PDT) treatment of skin complaints is described herein. The skin complaint being treated can be actinic keratosis (AK) or a basal cell carcinoma (BCC).
Opening claim text (preview).
1 . A method of treating a skin condition in an animal the method comprising adminisering a photosensitizer to the animal skin, wherein the photosensitizer treats the skin condition with photodynamic therapy (PDT), and wherein the photosensitizer is applied to the skin of the animal for a short period of time, and the skin condition is actinic keratosis or basal cell carcinoma. 2 . The method according to claim 1 , wherein the method reduces side effects associated with PDT. 3 . The method according to claim 1 , further comprising applying the photosensitizer to the skin of the animal for a period of from 5 minutes to 120 minutes. 4 . The method according to claim 1 , wherein the PDT includes a photoactivation achieved by artificial or natural light source. 5 . The method according to claim 1 , wherein the PDT comprises: a) administering to the animal a composition comprising the photosensitizer for a duration of from 5 minutes to 120 minutes; and b) photoactivating the photosensitizer for a duration of from 1 minute to 15 minutes with artificial light or from 0.5 hour to 3 hours with natural light. 6 . The method according to claim 5 , wherein the PDT comprises: a) administering to the animal a composition comprising the photosensitizer for a duration of from 15 minutes to 60 minutes; and b) photoactivating the photosensitizer for a duration of from 5 minutes to 10 minutes with artificial light or from 0.5 hour to 2 hours with natural light. 7 . The method according to claim 6 , wherein PDT comprises: a) administering to the animal a composition comprising the photosensitizer for a duration of 30 minutes; and b) removing the photosensitizer; and c) photoactivating the photosensitizer 2.5 hours later for a duration of 9 minutes with artificial light or of at least 2 hours with natural light. 8 . The method according to claim 1 , wherein the photosensitizer is selected from the group consisting of 5-ALA, 5-ALA derivatives, 5-MAL, 5-MAL derivatives, and compounds covered by general formula I: R 2 2 N—CH 2 COCH 2 —CH 2 CO—OR 1 (I) wherein: R 1 represents a substituted or unsubstituted straight, branched or cyclic alkyl group; and each R 2 independently represents a hydrogen atom or an optionally substituted alkyl group; and pharmaceutically acceptable salts thereof. 9 . The method according to claim 1 , wherein the photosensitizer is 5-ALA or 5-methyl ALA ester. 10 . The method according to claim 1 , wherein administering the photosensitizer to the animal is carried out with or without occlusion. 11 . The method according to claim 1 , wherein the photosensitizer is used in combination with a glucocorticosteroid. 12 . The method according to claim 3 , wherein the period of time is from 15 minutes to 60 minutes. 13 . The method according to claim 4 , wherein the artificial or natural light source is a LED or sunlight. 14 . The method according to claim 8 , wherein the alkyl group is a substituted or unsubstituted straight-chained alkyl group. 15 . The method according to claim 10 , wherein the administration of the photosensitizer is carried out with occlusion.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Antineoplastic agents · CPC title
for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title
Emollients or protectives, e.g. against radiation · CPC title
Anti-acne agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.